Biomaterial Database

Elevated alpha1-Antitrypsin serum levels in lung cancer patients. 1974

C C Harris, and A Primack, and M H Cohen

UI	MeSH Term	Description	Entries
D008175	Lung Neoplasms	Tumors or cancer of the LUNG.	Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D005260	Female		Females
D005779	Immunodiffusion	Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction.	Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D000515	alpha 1-Antitrypsin	Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES.	Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor

Related Publications

C C Harris, and A Primack, and M H Cohen

Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.

January 1977, Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,

C C Harris, and A Primack, and M H Cohen

Elevated plasma thymosin-alpha1 levels in lung cancer patients.

December 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,

C C Harris, and A Primack, and M H Cohen

Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene.

September 2003, Digestive diseases and sciences,

C C Harris, and A Primack, and M H Cohen

Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.

August 2008, Neuro endocrinology letters,

C C Harris, and A Primack, and M H Cohen

Alpha1-antitrypsin deficiency allele carriers among lung cancer patients.

May 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,

C C Harris, and A Primack, and M H Cohen

Behaviour of alpha1-antitrypsin in lung cancer.

January 1978, Scandinavian journal of respiratory diseases. Supplementum,

C C Harris, and A Primack, and M H Cohen

[Serum levels of alpha 1-antitrypsin in patients with lung cancer].

August 1977, Pneumonologia polska,

C C Harris, and A Primack, and M H Cohen

Serum levels and alpha1-antitrypsin phenotypes in active pulmonary tuberculosis.

January 1977, Acta geneticae medicae et gemellologiae,

C C Harris, and A Primack, and M H Cohen

Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival.

February 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,